For example, miR-146a/b was identified as an inhibitor for TRAF6 and interleukin-1 receptor-associated kinase (IRAK)1 in breast cancer cells MDA-MB-231 and downregulated TRAF6 eventually gave rise to the suppression of NF-κB activities (43). Here, TRAF6 is linked to breast cancer.